Abstract
Three hundred and thirty-three Shigella isolates obtained in 1986 to 1995 were tested for their susceptibilities to 19 antimicrobial agents. Nalidixic acid resistance had emerged in 59.6% of Shigella flexneri isolates during 1994 to 1995, with all tested resistant isolates having the mutation in gyrA encoding the Ser-83 alteration. Multiresistance (resistance to four or more agents) was more common in S. flexneri than in Shigella sonnei.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Anti-Infective Agents / pharmacology*
-
DNA Gyrase
-
DNA Topoisomerases, Type II / genetics
-
Drug Resistance, Multiple / genetics
-
Hong Kong
-
Humans
-
Microbial Sensitivity Tests
-
Nalidixic Acid / pharmacology*
-
Shigella flexneri / drug effects*
-
Shigella flexneri / genetics
-
Shigella sonnei / drug effects*
-
Shigella sonnei / genetics
Substances
-
Anti-Infective Agents
-
Nalidixic Acid
-
DNA Gyrase
-
DNA Topoisomerases, Type II